Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 160 – 16 JULY 2024   In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 96/24.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Stig Frederiksen, Head of Communications & Investor Relations, tel.: +45 32 71 08 55, e-mail: sfr@norden.com

Aquaporin-powered purifier now available in Turkey

Turkey's leading technology company, Vestel, has launched a water purifier named Vestel Rafine PRO in cooperation with Aquaporin on its website and in selected stores across Turkey.The Aquaporin Inside® technology powers the Vestel Rafine PRO  water purifier. The brand-new water purifier will be available to Turkish customers looking for an efficient, high-quality at-home water purifier. The Vestel Rafine PRO system offers high reduction rates for water contaminants. It also has leak detection, automatic flushing, and a

EQT Life Sciences invests in Asceneuron, a neurodegeneration therapeutics company, as part of USD 100 million Series C financing round

· EQT Life Sciences has invested in Asceneuron’s oversubscribed Series C and Prof. Philip Scheltens will join the Asceneuron Board of Directors · Asceneuron – which is developing small molecules targeting tau protein aggregation, a root cause of neurodegenerative disease – will use the funds to progress its lead asset ASN51 into Phase 2 clinical development for the treatment of Alzheimer’s diseaseEQT Life Sciences is pleased to share that the LSP Dementia Fund has invested in Asceneuron SA (“Asceneuron” or “the Company”), a clinical stage biotech company developing small molecules,

OpticOdds Launches Suite of New Automation

OpticOdds, the premier feed provider for top operators, has launched a suite of new automation features for sports bettors’ trading alerts. These enhancements allow seamless integration of trading alerts on both the Odds Screen and Slack without any engineering work.The Consensus Line allows users to create blended odds from selected sportsbooks, ensuring the most balanced and accurate odds are visible. Access to this data facilitates informed betting decisions by combining data from multiple sources. Outlier alerts mean that bettors are aware of the best odds, receiving instant

Presentation of K-Fastigheter’s interim report January-June 2024

On July 23[rd], 2024, at 9 AM CEST, K-Fast Holding AB (“K-Fastigheter”) publishes its interim report for the second quarter 2024. The report will be presented in a pre-recorded audio cast at 10 AM CEST the same day. Jacob Karlsson, CEO, and Martin Larsson, CFO, will present the earnings and operations. The presentation materials (slides and sound) will be available at www.k-fastigheter.com/en/investors/presentations  The

Republic of Moldova designated to lead the Global Medical Tourism Council

The Republic of Moldova, represented by the Medical Tourism Association, has been elected to hold the Presidency of the Global Medical Tourism Council (GHTC) for the next two years, 2024 - 2026. This prestigious position, decided at the GHTC General Assembly, signifies Moldova's growing influence in the global medical tourism industry. Competing against Germany and Saudi Arabia, Moldova  secured the majority of votes from over 50 participating countries, reflecting its emerging prominence in this sector.   "Our overarching commitment is to pursue

Trade Update: White Pearl Technology Group pursues strong growth trajectory in H1 2024

White Pearl Technology Group (WPTG) continues to show strong organic growth, with revenue increasing by 20% in the first half of 2024 (H1 2024) compared to the corresponding period in 2023. The core business has expanded and grown across all segments. Anticipated profit growth is over 12% compared to the corresponding period in 2023.The numbers posted in H1 exclude the effects of the Ayima acquisition and subsequent unilateral declaration of bankruptcy by the board of Ayima. Audit opinion and outcome of the liquidation process are currently outstanding and will be included in the H1 report

Invitation to UPM’s webcast on half year financial report 2024

(UPM, Helsinki, 16 July 2024 at 10:00 EEST) – UPM will publish its half year financial report on Tuesday 23 July 2024 at 09:30–10:00 EEST. After publication, the report will be available on the company website at www.upm.com .   A webcast and a conference call for analysts and investors will start at 13:15 EEST. The half year report will be presented in English by President and CEO Massimo Reynaudo and CFO Tapio Korpeinen. Participants can follow the webcast online via this link .   Participants wishing to

Teollisuuden Voima Oyj’s Interim Report 1 January–30 June 2024

During the first half of 2024, Teollisuuden Voima Oyj’s (TVO) electricity generation at the Olkiluoto 1 (OL1), Olkiluoto 2 (OL2) and Olkiluoto 3 (OL3) plant units continued safely.The total electricity production of the plant units during the period in review was 10,372 (11,030) GWh.  An environmental impact assessment programme (EIA programme) concerning the possible service life extension and power uprating of the OL1 and OL2 plant units was submitted to the Ministry of Economic Affairs and Employment (MEAE), which acts as the coordinating authority, in January 2024 and a public event

47,000 companies have not filed their beneficial owner details – may now risk deregistration

The Finnish Patent and Registration Office (PRH), which maintains the Finnish Trade Register, will deregister companies that have not filed their beneficial owner details despite requests to do so. This week, the PRH sent reminder letters to thousands of limited liability companies and co-operatives that have not filed their beneficial owner details. The PRH may deregister these companies if they – despite reminders – do not file their beneficial owner details by the deadline.According to the Finnish Trade Register Act, all limited liability companies and co-operatives must file details of

Clean Industry Solutions Holding Europe AB (publ) has applied for delisting of the company's shares from Nasdaq First North Growth Market

The liquidator of Clean Industry Solutions Holding Europe AB (publ) (the "Company") has today submitted an application for delisting of the Company's shares from Nasdaq First North Growth Market. The last day of trading in the Company's shares on Nasdaq First North Growth Market will be announced as soon as the Company has received confirmation from Nasdaq.On 28 June 2024, the Annual General Meeting of the Company resolved on voluntary liquidation in accordance with Chapter 25, Section 3 of the Swedish Companies Act. The estimated time for final distribution of assets is Q2 2025.

Invitation to conference call, July 23 at 13:00 (CEST)

Studsvik AB presents its Interim Report for the Second Quarter 2024 and hereby invites media and analysts to a conference call held in English on Tuesday, July 23 at 13:00 (CEST).Studsvik’s Interim Report for the Second Quarter 2024 will be distributed at approximately 10:30 am (CEST), July 23. As of this time, the report will also be available at www.studsvik.com.   The call will be held in English, starting 13:00 (CEST).   If you wish to participate via webcast please use the link below. Via the webcast you are able to ask written questions. Studsvik Q2 Report 2024 (

Vaisala Xweather delivers worldwide real-time air quality data to drivers of BMW Group cars

Vaisala Xweather air quality data will be available to drivers of the new BMW X1, X2, and 2-Series Active Tourer cars, as well as MINI and MINI Countryman, letting them make healthier route choices that avoid polluted areas, as well as adjust indoor airflow to prevent potential health risks.Espoo, Finland (July 16th, 2024) Vaisala , a global leader in measurement technology, partners with the BMW Group to implement real-time Xweather air quality data  in the new BMW X1, X2, and 2 series, as well as MINI and MINI Countryman, through

Repurchases of shares week 28, 2024

Between 8 July and 12 July 2024 Attendo AB (LEI code 549300KEJDL2FNITUW65) (“Attendo”) has repurchased in total 133,590 own shares (ISIN: SE0007666110) as part of the repurchase program initiated by the Board.The repurchases form part of the repurchase program of a maximum of 16,138,659 own shares for a total maximum amount of SEK 110,000,000 that Attendo announced on 24 April 2024. The repurchase program, which runs between 29 April 2024 and 18 July 2024, is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 and the Commission Delegated Regulation (EU) No

Elkem ASA – Sale of shares under share incentive programme

Oslo, 16 July 2024 Reference is made to the previous stock exchange release on 15 July 2024, regarding exercise of share options under Elkem ASA's ("Elkem" or the "Company", OSE ticker code: "ELK") share incentive programme. Pursuant to the sales process conducted by a third party this primary insider has sold the following number of option shares at a price of NOK 22.8001 per share:  · Morten Magnus Voll (SVP Strategy and Business Development), sold 25,000 shares at a price of NOK 22.8001 per share, following which he holds 175,000 options and 10,384 shares in the Company.

Neste and Mitsubishi Corporation agree on strategic partnership to develop supply chains for renewable chemicals and plastics

Neste Corporation, Press Release, 16 July 2024 at 9.00 am (EET) Photo: Signing ceremony between Neste and Mitsubishi Corporation with Carrie Song, Senior Vice President, Commercial at Neste Renewable Products and Yoshiyuki Watanabe, Division COO, Business Development Div. at Mitsubishi Corporation. Source: Mitsubishi CorporationNeste and Mitsubishi Corporation (“MC”) have agreed to establish a strategic partnership focusing on developing value chains for renewable chemicals and plastics for and with Japanese brands. The partners are targeting brands in industries such as food

Invitation to presentation of Sedana Medical’s interim report for the second quarter 2024

Sedana Medical AB (publ) plans to present its interim report for the second quarter of 2024 on Tuesday July 23 at 13:30 CET.According to the financial calendar, Sedana Medical plans to publish the interim report for the second quarter 2024 on Tuesday July 23 at approximately 07.00 CET. Sedana Medical hereby invites to a presentation of the report on the same day, where the CEO Johannes Doll will present the report in English together with Johan Spetz, CFO, and Peter Sackey, CMO, as well as answer questions.   Date: Tuesday, July 23, 2024 Time (CET): 13:30   More info and link

Interim report 1 January – 30 June 2024

April – June · Revenue for the quarter amounted to SEK 157.5 million (149.7), a year-on-year increase of 5 per cent. · Net operating income amounted to SEK 96.9 million (95.7), up 1 per cent year-on-year. · Income from property management amounted to SEK 37.3 million (40.3), a year-on-year decrease of SEK 3 million. · Changes in the value of investment properties amounted to SEK 11.3 million (-113.7) and changes in the value of derivatives to SEK -1.7 million (35.4). · Earnings totalled SEK 28.7 million (-34.5), corresponding to SEK 0.22 per share (-0.26). · The loan-to-

Q2 2024: Significant progress on strategic initiatives

Important events during the second quarter · Net sales in Q2 amounted to SEK 178.9 m, corresponding to an increase of 25% compared to last year (23% adjusted for currency effects). · The EBITDA margin was 19%, corresponding to an increase of 10 percentage points compared to last year. · Probi and ProViva celebrated 30 years of collaboration, highlighting the success with ProViva's popular probiotic drinks containing Lp299v[®]. · Probi strengthened its presence in APAC by launching China Innovation Day, a customer-oriented event focused on fostering collaborations in the

Transaction in Own Shares

    16 July 2024 Vesuvius plc Share Buyback Programme – Transactions in Own Securities   Vesuvius plc (the "Company") announces that it has purchased the following number of its Ordinary Shares of 10p each from Jefferies International Limited (the “Broker”), pursuant to the terms of its Share Buyback Programme announced on 4 December 2023:   +---------------------------------------------------------------+----------+|Date of purchase: |15/07/2024|+--------------------------------------------------------------

Q4 and FY 2024 Operating Update

    16 July 2024  LSE: PDL     Petra Diamonds Limited (Petra or the Company)   Q4 and FY 2024 Operating Update   Richard Duffy, Chief Executive Officer of Petra, commented:   “At our recent investor day, we unveiled our plans to demonstrate Petra Diamonds’ enhanced resilience and compelling value proposition. We are focussed on delivering our target of US$30 million in sustainable annual cost savings together with a smoothed capital profile, to generate net free cash from the current financial year onwards. This will allow us to continue to

Sobi Q2 2024 report: Strong delivery driven by robust portfolio performance

Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the second quarter 2024Second Quarter 2024   •          Total revenue increased 12 per cent, 11 per cent at constant exchange rates, (CER)1, to SEK 5,442 M (4,872) •         Haematology revenue increased 13 per cent at CER to SEK 3,866 M (3,430), reflecting growth in all medicines, mainly driven by strong sales of Doptelet® excluding sales to China of SEK 928 M (567), sales of Vonjo® of SEK 347 M (36) and sales of Aspaveli®/Empaveli® of SEK 251 M (144) •         Immunology revenue increased 7 per cent at

There are no items matching the current filter
There are no more items matching the current filter
Back to top